News
Saudi Arabia invites Indian pharma companies for strategic partnerships & investment opportunities: Shardul Nautiyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] In a major bo ...
TN PTA appeals to Union Finance Minister for complete exemption of all life-saving medicines from GST: Peethaambaran Kunnathoor, Chennai Thursday, July 31, 2025, 08:00 Hrs [IST] T ...
VGGS commissioned in Gujarat: Dr. H G Koshia: Shardul Nautyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] Out of the total 376 projects in ...
DBT engaged in various initiatives on alternatives to animal testing: Minister: Our Bureau, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] Even as the Department of Biotechnol ...
SJM demands elimination of animal studies, more clarity on Biosimilar Guidelines: Gireesh Babu, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] The Swadeshi Jagran Manch (SJM), ...
On July 24, India and the UK have signed a Free Trade Agreement in London in the presence of Indian Prime Minister Narendra Modi and UK premier Keir Starmer. The much-awaited Indo-UK FTA marks a ...
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
MAIA Biotechnology receives US FDA fast track designation for ateganosine for the treatment of non-small cell lung cancer: Chicago Wednesday, July 30, 2025, 17:00 Hrs [IST] MAIA B ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results